Elsevier

Health Policy

Volume 111, Issue 2, July 2013, Pages 135-148
Health Policy

Review
Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence?

https://doi.org/10.1016/j.healthpol.2013.04.003Get rights and content

Abstract

Background and objectives

Policies to expand the traditional role of community pharmacists have been implemented or at least considered in a number of countries, as advocated by academics, professional organizations, and governments. Such reforms come on the heel of pressing system-wide challenges. At a time of growing interest in evidence-based policymaking, what is the policy-relevant evidence base in support of this new expanded role for community pharmacists?

Methods

An umbrella review was conducted to identify published systematic reviews of evidence on the effectiveness of community pharmacist interventions. Findings of the identified reviews were documented according to Pharmaceutical Care and Total Pharmacy Care models, and evaluated on the basis of internal and external validity. The internal validity of identified reviews was evaluated in terms of the comparability of populations, interventions, and outcomes. External validity was based on the reproducibility and generalizability of review findings.

Results

Thirty-three systematic reviews published since 2000 evaluated the evidentiary support for the expanded role of community pharmacists, which focuses on two primary objectives: (1) to encourage the effective, safe and appropriate use of medicines and (2) to promote the prevention and management of chronic diseases. The results of most systematic reviews were mixed, with unclear policy relevance. Important methodological drawbacks were found in terms of study identification and selection, and comparability of interventions and outcomes. In addition, the external validity of the findings was inconclusive on the basis of reproducibility and generalizability.

Conclusions

There is inconclusive evidence in support of expanding the role of community pharmacists. This raises an important question: should the pharmacy profession only undertake tasks for which there is strong policy relevance with evidence of economic and public health benefits? In spite of this tension between the necessity to formulate new policies during a period of economic constraints and the level of corresponding evidence, several countries have begun entertaining policies to equip community pharmacists with patient-centered responsibilities. As implementing such expanded roles requires significant changes in the wider health care system, further research is needed to evaluate country-level policy developments.

Introduction

The increasingly orthodox approach to formulating policies is to “do what the science says.” Many now believe that policy-making should be evidence-based in order to remove its “political” components [1]. The principle of evidence-based policymaking has indeed permeated all areas of public policy, including the health sector [2].

The increasing interest in evidence-based policymaking has implications for the community pharmacy profession. Recently, experts from academia and professional organizations have advocated in favour of devising policies to equip community pharmacists with expanded roles and responsibilities [3], [4]. Several international and national reviews on the role of community pharmacists have concluded that pharmacists could adopt an expanded, patient-centered role and could contribute to safe, effective and economic use of drugs [5], [6].

Triggering this patient-focused role two decades ago, Hepler and Strand defined pharmaceutical care as “the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life” [7]. Going beyond pharmaceutical care, Holland and Nimmo defined the Total Pharmacy Care Model as the combination of five existing practice models: drug information, self-care, clinical pharmacy, pharmaceutical care, and distribution [8]. As such, total pharmacy care is “the delivery of a comprehensive range of services that result in the maximum possible contribution to the health of a nation's population within the limits of the health care delivery structure.”

Indeed, community pharmacists have the potential to improve patients’ outcomes and reduce the costs of care by promoting health, preventing illness and avoiding adverse events [9]. Pharmacists are the third largest health care professional group in the world after physicians and nurses [10]. Community pharmacists are at times patients’ first and only contact with the health care system [11] and are often described as the most accessible of all health professionals [12]. Consequently, patient-centered responsibilities would be commensurate with the profession's extensive training and expertise.

Some governments appear to share the enthusiasm for expanding the role of community pharmacists. Across a number of countries, the emerging (albeit slowly) comprehensive role for community pharmacists implies a reconfiguration of the role of community pharmacists within the health system (see Fig. 1). With this understanding, pharmacists’ existing responsibilities towards patient welfare serve as a basis for policies, which grant them greater oversight over the proper and cost-effective use of medicines. The expectation is that, taken together, these activities will encourage care delivery that is coordinated across the health system. This will help to reduce drug-related adverse events and complications associated with long-term chronic conditions (e.g., cardiovascular disease and diabetes). In turn, it should also minimize office visits, hospitalizations and readmissions, and emergency department visits, all of which have considerable economic, clinical, and humanistic consequences.

Although expanding the role of community pharmacists is becoming an important policy objective, the evidence base for such policies has not been comprehensively evaluated. Numerous systematic reviews exist but whether these are adequate for policymaking is not clear. Distinguishing between evidence that is experimental in nature and evidence that is relevant for policymaking, it is important to assess the policy-relevance of the existing evidence on the basis of both its internal validity (“trustworthiness”) and external validity (“transferability”).

Our paper is consequently guided by the following research question: What is the policy-relevant evidence base in support of the new expanded roles for community pharmacists advocated by academics, professional organizations, and governments? To address this research question, we first briefly review the emerging comprehensive roles and responsibilities advocated by academic experts, professional organizations, and governments. We then critically review the scope, quality, and relevance of the corresponding systematic review evidence currently available to inform such policies.

In the next section, we outline the methods used to identify the relevant policy materials and corresponding systematic review evidence. In the third section, we report the findings of our review of systematic reviews and highlight the variability across reviews in terms of their findings. As we discuss in the final section of the paper, the drawbacks of most existing reviews raise an important question: should the pharmacy profession only undertake tasks for which there is strong policy relevance with evidence of economic and public health benefits?

Section snippets

Methods

First, we performed a review of academic publications as well as policy documents from governmental agencies and professional associations. The objective of this non-systematic, exploratory review was to compile a list of new roles and responsibilities for community pharmacists across Europe and North America. This was based on reviewing the Pharmaceutical Care and Total Pharmacy Care models, and searching governmental agency and professional association websites [17], [18], [19], [20], [21].

Results

Table 1 provides a list of expanded roles and responsibilities of community pharmacists as identified in governmental and professional association publications, and categorized to reflect the Pharmaceutical Care and Total Pharmacy Care models. Within this expanded role, community pharmacists have two primary objectives: (1) to encourage the effective, safe and appropriate use of medicines and (2) to promote the prevention and management of chronic diseases. This expanded role involves

Discussion

In this study, we reviewed the systematic review evidence in support of policy developments in expanding the role of community pharmacists. We included 33 systematic reviews of the literature published since 2000. According to some reviews, community pharmacists were highly effective in promoting the effective, safe, and appropriate use of medicines. According to others, the findings were either inconsistent or inconclusive with no clear implications for expanding the role of community

Conclusions

Scientific evidence is essential for informing health policy decisions. The notion of evidence-based policymaking has important implications for the community pharmacy profession as it is moving towards a more patient-centered role. A number of countries are introducing policies to formally expand the role played by community pharmacists in their respective health systems. The systematic review evidence in support of this transformation is mixed and inconclusive. Moreover, there are important

References (85)

  • World Health Organisation

    Role of the Pharmacist in the Health Care System

    (1990)
  • International Pharmaceutical Federation

    Statement of policy on Good Pharmacy Education Practice

    (2000)
  • C.D. Hepler et al.

    Opportunities and responsibilities in pharmaceutical care

    American Journal of Hospital Pharmacy

    (1990)
  • R.W. Holland et al.

    Transitions, part 1: beyond pharmaceutical care

    Am J Health Syst Pharm

    (1999)
  • M. Smith et al.

    In Connecticut: improving patient medication management in primary care

    Health Affairs

    (2011)
  • International Pharmaceutical Federation. Human resources - the 2012 FIP Global Pharmacy Workforce Report. The Hague:...
  • I. Habeed et al.

    Pharmacists in the wider public health workforce – a review

    Archives of Pharmacy Practice

    (2012)
  • Ordre des Pharmaciens

    Livre Blanc – La pharmacie d’officine en France. Bilans et perspectives

    (2008)
  • Department of Health

    Pharmacy in England. Building on Strengths, Delivering the Future

    (2008)
  • Canadian Pharmacists Association

    Report to the House of Commons Standing Committee on Health. Examination into chronic diseases in Canada's aging population and the role of the pharmacist

    (2011)
  • M. Bouvy et al.

    White paper on pharmacy in The Netherlands. Position on pharmacy, pharmacists and pharmacy practice

    (2011)
  • Canadian Pharmacist Association. 2013; http://www.pharmacists.ca/ [accessed...
  • Department of Health. 2013; http://www.dh.gov.uk/en/index.htm [accessed...
  • General Pharmaceutical Council. 2013; http://www.pharmacyregulation.org/ [accessed...
  • Ordre des Pharmaciens. 2013; http://www.ordre.pharmacien.fr/ [accessed...
  • Royal Dutch Pharmacists Association. 2013; http://www.knmp.nl/ [accessed...
  • B.J. Shea et al.

    Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

    BMC Medical Research Methodology

    (2007)
  • A. Melchiors et al.

    An analysis of quality of systematic reviews on pharmacist health interventions

    International Journal of Clinical Pharmacy

    (2012)
  • L.A. Bero et al.

    Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes

    Cochrane Database of Systematic Reviews

    (2000)
  • N. Nkansah et al.

    Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns

    Cochrane Database of Systematic Reviews

    (2010)
  • M.A. Chisholm-Burns et al.

    US pharmacists’ effect as team members on patient care: systematic review and meta-analyses

    Medical Care

    (2010)
  • S. Royal et al.

    Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis

    Quality Safety Health Care

    (2006)
  • R. Holland et al.

    Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis

    British Journal of Clinical Pharmacology

    (2008)
  • R.L. Castelino et al.

    Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services

    Annals of Pharmacotherapy

    (2009)
  • J. Robertson et al.

    The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature

    International Journal of Pharmacy Practice

    (2010)
  • V. von Gunten et al.

    Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review

    Pharmacy World & Science

    (2007)
  • K.A. Al-Jumah et al.

    Impact of pharmacist interventions on patients’ adherence to antidepressants and patient-reported outcomes: a systematic review

    Patient Prefer Adherence

    (2012)
  • B.L. Van Wijk et al.

    Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review

    Annals of Pharmacotherapy

    (2005)
  • K. Sinclair Hazel et al.

    Community pharmacy personnel interventions for smoking cessation

    Cochrane Database of Systematic Reviews

    (2004)
  • A. Blenkinsopp et al.

    Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease

    Journal of Public Health

    (2003)
  • L.A. Dent et al.

    Tobacco interventions delivered by pharmacists: a summary and systematic review

    Pharmacotherapy

    (2007)
  • V. Santschi et al.

    Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials

    Archives of Internal Medicine

    (2011)
  • Cited by (80)

    • The evolving profile of cognitive pharmaceutical services in Australia

      2022, Research in Social and Administrative Pharmacy
    • Securing a sustainable and fit-for-purpose UK health and care workforce

      2021, The Lancet
      Citation Excerpt :

      In Northern Ireland, the Minor Ailments Scheme aims to empower patients to self-treat minor illnesses using the knowledge and skills of their pharmacist, thereby easing pressure on primary care and emergency services. These initiatives point to a need to evaluate the expanding role of community pharmacists, as the available evidence is currently mixed and inconclusive.111 Other examples of task shifting include the introduction of new roles, such as physician associates and nurse practitioners.

    • Quality of tuberculosis care by pharmacies in low- and middle-income countries: Gaps and opportunities

      2020, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
    View all citing articles on Scopus
    View full text